NCT01946802

Brief Summary

Current guidelines recommend the use of sedatives and neuromuscular blocking agents to avoid shivering during therapeutic hypothermia in cardiac arrest victims. Therefore, it is difficult to detect seizure and the frequent or continuous EEG monitoring is recommended. However, it is difficult to follow this recommendation in most clinical situations due to the lack of specialized devices and persons. The purpose of this study is whether SEDline (frontal 4-channel EEG device) has a diagnostic value to detect seizure during therapeutic hypothermia in cardiac arrest victims.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 20, 2013

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

March 23, 2021

Completed
Last Updated

March 23, 2021

Status Verified

March 1, 2021

Enrollment Period

1.8 years

First QC Date

September 11, 2013

Results QC Date

October 14, 2016

Last Update Submit

March 21, 2021

Conditions

Keywords

Heart arrestCardiopulmonary resuscitationHypothermia inducedSeizuresElectroencephalography

Outcome Measures

Primary Outcomes (1)

  • Percentage of Seizure-positive and Seizure-negative That Were Correctly Classified by the SEDline in All Evaluated Cases

    Conventional EEG (gold standard for seizure detection) and SEDline monitoring will be conducted simultaneously for 30 minutes at During therapeutic hypothermia and rewarming (12 \~ 72 hours after cardiac arrest). Then, data retrieved from the conventional EEG and SEDline will be interpreted and analyzed for the presence of seizure.

    Within 72 hours after cardiac arrest

Secondary Outcomes (5)

  • Sensitivity of SEDline for Seizure Detection

    Within 72 hours after cardiac arrest

  • Specificity

    Within 72 hours after cardiac arrest

  • Positive Predictive Value

    Within 72 hours after cardiac arrest

  • Negative Predictive Value

    Within 72 hours after cardiac arrest

  • Area Under Receiver Operating Characteristics Curve (AUC) of SEDline for Seizure Detection

    Within 72 hours after cardiac arrest

Study Arms (1)

Frontal 4 channel EEG

Consecutive comatose patients admitted to the emergency ICU for postresuscitation care following successful cardiopulmonary resuscitation after nontraumatic out-of-hospital and in-hospital cardiac arrest.

Device: Frontal 4 channel EEG

Interventions

Simultaneous conventional EEG and SEDline monitoring for 30 minutes during and after therapeutic hypothermia

Also known as: SEDline, Masimo corporation
Frontal 4 channel EEG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Comatose cardiac arrest survivors admitted to a 12-bed emergency intensive care unit of Seoul National University Hospital, Seoul, Republic of Korea.

You may qualify if:

  • Consecutive comatose patients admitted to the emergency ICU for postresuscitation care following successful cardiopulmonary resuscitation after nontraumatic out-of-hospital and in-hospital cardiac arrest.
  • Cardiac arrest is defined as cessation of cardiac mechanical activity, confirmed by the absence of a detectable pulse, unresponsiveness, and apnea.

You may not qualify if:

  • Age \< 18 years old
  • Contraindication to therapeutic hypothermia: active life-threatening bleeding, septic shock, or refractory fatal arrhythmia..
  • Intracranial pathology including hemorrhage or tumor
  • Visible generalized seizure before the study enrollment
  • Advanced directives to withdraw life-sustaining treatment
  • No informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Emergency Medicine, Seoul National University Hospital

Seoul, 110-744, South Korea

Location

Related Publications (3)

  • HOCKADAY JM, POTTS F, EPSTEIN E, BONAZZI A, SCHWAB RS. ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE CEREBRAL ANOXIA FROM CARDIAC OR RESPIRATORY ARREST. Electroencephalogr Clin Neurophysiol. 1965 May;18:575-86. doi: 10.1016/0013-4694(65)90075-1. No abstract available.

    PMID: 14296835BACKGROUND
  • Rossetti AO, Urbano LA, Delodder F, Kaplan PW, Oddo M. Prognostic value of continuous EEG monitoring during therapeutic hypothermia after cardiac arrest. Crit Care. 2010;14(5):R173. doi: 10.1186/cc9276. Epub 2010 Sep 29.

    PMID: 20920227BACKGROUND
  • Crepeau AZ, Rabinstein AA, Fugate JE, Mandrekar J, Wijdicks EF, White RD, Britton JW. Continuous EEG in therapeutic hypothermia after cardiac arrest: prognostic and clinical value. Neurology. 2013 Jan 22;80(4):339-44. doi: 10.1212/WNL.0b013e31827f089d. Epub 2013 Jan 2.

    PMID: 23284064BACKGROUND

MeSH Terms

Conditions

Heart ArrestSeizures

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Since the SEDline system provides 4-channel-processed EEG monitoring in the frontal area, focal seizures could not be detected and spatial localization of the seizure might be difficult.

Results Point of Contact

Title
Pf. Gil Joon Suh
Organization
Seoul National University Hospital

Study Officials

  • Gil Joon Suh, Prof

    Seoul National University Hospital

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 11, 2013

First Posted

September 20, 2013

Study Start

December 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

March 23, 2021

Results First Posted

March 23, 2021

Record last verified: 2021-03

Locations